Two Sigma Securities, LLC Genprex, Inc. Transaction History

Two Sigma Securities, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.19 - $0.37 $556 - $1,083	2,929 Added 16.32%	20,880 $4,000
Q3 2023 Nov 14, 2023	BUY	$0.37 - $1.04 $6,641 - $18,669	17,951 New	17,951 $7,000
Q1 2023 May 15, 2023	BUY	$0.76 - $1.78 $58,686 - $137,449	77,219 New	77,219 $70,000
Q3 2022 Nov 14, 2022	BUY	$1.32 - $58.0 $18,412 - $809,042	13,949 New	13,949 $20,000
Q1 2022 May 16, 2022	SELL	$1.82 - $3.5 $57,761 - $111,079	-31,737 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.21 - $2.7 $38,401 - $85,689	31,737 New	31,737 $42,000
Q3 2019 Nov 14, 2019	SELL	$0.8 - $1.18 $8,933 - $13,177	-11,167 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$1.2 - $1.85 $13,400 - $20,658	11,167 New	11,167 $14,000

600

Ticker GNPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,300
Market Cap $64.3M
Description
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incor...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.